Clinical Trials Directory

Trials / Completed

CompletedNCT02646969

Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
691 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
0 Days – 7 Days
Healthy volunteers
Accepted

Summary

Growth and metabolic biomarkers of healthy term infants fed formulas with staged protein concentrations over the first year of life

Detailed description

The overall objective of this study is to assess growth and biomarkers of energy and protein metabolism in healthy term infants fed with two different study formula regimens from birth to 12 months of age and to follow up the infants to 4 years of age.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFormula regimen 1
DIETARY_SUPPLEMENTFormula regimen 2

Timeline

Start date
2015-10-01
Primary completion
2022-07-01
Completion
2022-07-01
First posted
2016-01-06
Last updated
2025-05-15

Locations

9 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02646969. Inclusion in this directory is not an endorsement.

Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Y (NCT02646969) · Clinical Trials Directory